人溶酶体酸性b-葡萄糖脑苷脂酶基因的克隆及其在COS7细胞中的表达

从人胎盘组织提取总RNA, 采用RT-PCR扩增人溶酶体酸性b-葡萄糖脑苷脂酶(Lysosomal acid b-glucosidase, GlcCerase)基因编码区的全部序列, 并克隆到pMD-19T载体上, 构建克隆载体pMD-GlcCerase。经测序验证后, 将GlcCerase亚克隆至表达载体pEGFP-C1上, 构建了人GlcCerase绿色荧光蛋白真核表达载体pEGFP-GlcCerase。采用脂质体法将其瞬时转染至COS7细胞系后, 在细胞中检测到了GlcCerase基因, 并在细胞裂解产物中检测到了GlcCerase生物活性的表达。GlcCerase基因的克隆及其表达, 为进一步了解GlcCerase基因的功能以及利用转基因动物乳腺生物反应器高效生产GlcCerase奠定了基础。     

人溶酶体酸性β-葡萄糖脑苷脂酶基因的克隆及其在COS7细胞中的表达

从人胎盘组织提取总RNA,采用RT-PCR扩增人溶酶体酸性β-葡萄糖脑苷脂酶(Lysosomal acid β-glucosidase,GlcCerase)基因编码区的全部序列,并克隆到pMD-19T载体上,构建克隆载体pMD-GlcCerase.经测序验证后.将GlcCerase亚克隆至表达载体pEGFP-C1上,构建了人GlcCerase绿色荧光蛋白真核表达载体pEGFP-GlcCerase.采用脂质体法将其瞬时转染至COS7细胞系后,在细胞中检测到了GlcCerase基因,并在细胞裂解产物中检测到了GlcCerase生物活性的表达.GlcCerase基因的克隆及其表达,为进一步了解GlcCerase基因的功能以及利用转基因动物乳腺生物反应器高效生产GlcCerase奠定了基础.     

人角质化细胞生长因子-2基因的克隆、表达及产物的纯化、鉴定

用高表达菌株BL21codon plus compentent cells表达重组人角质化细胞生长因子(Hkgf-2)蛋白并初步纯化和检测其活性。通过RTPCR从流产胎儿肺组织中钓取hKGF-2cDNA,将其克隆入pBV220载体质粒。在大肠杆菌BL-21codon plus compent cells中表达hKGF-2蛋白。采用亲和层析和离子交换层析分离纯化,以细胞增殖实验测定表达蛋白的生物活性。结果显示,hKGF-2蛋白在BL21中得到高效表达;hKGF-2蛋白能刺激NIH3T3细胞的增殖,具有显著的促有丝分裂活性。     

人角质细胞生长因子2基因的克隆及其在大肠杆菌中的表达

目的:构建人角质细胞生长因子2(hKGF2)基因的高效原核表达载体pET-30a( )-hKGF2,并在大肠杆菌BL21(DE3)中获得表达。方法:从培养的人胚胎肺成纤维细胞中提取总RNA,采用RT-PCR技术扩增出去除了信号肽部分的hKGF2基因,克隆到pMD18-T载体,经DNA序列分析后与pET-30a( )表达载体连接,在大肠杆菌BL21(DE3)诱导表达6×His-hKGF2,用SDS-PAGE及Western印迹鉴定表达蛋白。结果:构建了表达载体pET-30a( )-hKGF2,经IPTG诱导后,表达的重组蛋白理论相对分子质量约为23000,约占菌体总蛋白的20%。结论:6×His-hKGF2蛋白在大肠杆菌BL21(DE3)中为可溶性高效表达,为获得高纯度、高活性的产物,以及进一步的大规模生产和应用研究奠定了基础。     

青杨脊虎天牛CYP4G2基因片段的克隆、序列分析与表达

根据报道的十几种昆虫CYP4家族基因的氨基酸序列保守区域设计一对引物,利用RT-PCR技术扩增编码青杨脊虎天牛Xylotechus rusticus中肠细胞色素氧化酶CYP4G2蛋白的cDNA片段,构建原核表达载体pET-CYP4G2,将其转化入大肠杆菌Escherichia coli JM109中表达。序列分析结果表明,该基因(CYP4G2,GenBank登录号为EF429250)保守区域阅读框全长387 bp,编码129个氨基酸残基,预测分子量和等电点分别为16.9 kD和5.75;推导的氨基酸序列与已报道的昆虫CYP4家族氨基酸序列一致性较高（63%～86%）,且具有细胞色素氧化酶的典型特征。IPTG诱导后,SDS-PAGE电泳检测到一条22 kD大小的外源蛋白,与预测融合蛋白的分子量大小相应。CO差光谱分析证明重组菌表达了有活性的pET-CYP4G2。     

人淋巴细胞CD2基因5‘侧翼序列的克隆和鉴定

本文报告以ＣＤ２ｃＤＮＡ５＇端的片段作探针,从人Ｔ淋巴细胞基因组文库筛选阳性重组克隆,经限制性内切酶降解和Ｓｏｕｔｈｅｒｎ杂交分析,证明其中一个阳性克隆的插入片段中含ＣＤ２基因５＇侧翼顺序。经插入片段的亚克隆、限制性内切酶图谱及ＤＮＡ序列分析,鉴定出一含转录起始点及其上游序列的４．ｋｂ片段。将此片段中含转录起始点和两个ＤＮａｓｅＩ高敏感位点的２．５ｋｂ片段定向克隆到以虫萤光素酶为报告基因的表达载体     

人NDRG2基因截短体在pEGFP-C2真核表达载体中的表达和鉴定

目的:在pEGFP-C2真核表达载体中表达人NDRG2基因的截短部分并进行鉴定.方法:以含有人NDRG2基因的pGKBT7质粒为模板,通过PCR的方法扩增获得截短的人NDRG2基因,然后克隆入表达载体pEGFP-C2;以荧光显微镜观察和WesternBlotting方法对表达产物进行鉴定.结果:表达产物中在分子量67kD左右可见与目的蛋白分子量相符的条带,该条带可被Ndrg2单克隆抗体特异性识别.结论:构建了截短的人NDRG2基因真核表达载体,并在真核细胞中(HEK-293)获得成功表达.     

巨大芽孢杆菌青霉素G酰化酶基因的克隆和表达

我们分离到了一株产生分泌型青霉素G酰化酶的巨大芽孢杆菌(Bacillus megateriumBM1)。用pBR322作载体,将该菌的青霉索G酰化酶基因克隆到大肠杆菌(Escherichia coliMcl061)中,得到含有9．9kb插人片段的重组质粒pBmPA4。分析了该质粒的限制酶酶切图谱,并经体外缺失获得含4．9kb插入片段的质粒pBmPA5。pBmPA4和pBmPA5在E·coliMcl061中均能表达,表达受苯乙酸诱导。     

口蹄疫病毒P1＋2A基因在BHK-21细胞中的表达

本研究将已构建好的、包含口蹄疫病毒P1＋2A基因的重组表达质粒pQE—Tri／PI＋2A经质脂体2000转染哺乳动物细胞BHK-21,转染后一定时间进行检测。通过SDS—PAGE、Western—blotting、荧光抗体染色、ELISA等检测方法表明,FMDVPI＋2A基因片段在BHK-21细胞中成功表达,表达的蛋白能被口蹄疫阳性血清所识别而且具有良好的生物学活性。这一结果的取得,为进一步研制新型口蹄疫基因工疫苗及其配套诊断试剂奠定了基础。     

人肾细胞癌细胞阳离子脂质体的转染效率

以ＭＴＳ染色法测定实验剂量的Ｌｉｐｏｆｅｃｔｉｎ对细胞的毒性作用,以β－半乳糖苷酶基因为报告基因,通过Ｌｉｐｏｆｅｃｔｉｎ而转染,用Ｘ－ｇａｌ染色法,测定转染效率,结果表明实验剂量（１０μｇ／ｍｌ）的Ｌｉｐｏｆｅｃｔｉｎ对细胞生长无明显毒性。Ｌｉｐｏｆｅｃｔｉｎ对多数肾细胞癌细胞的转染是有效的,且转染效率随Ｌｉｐｏｆｅｃｔｉｎ 度的增高（２．５－１０μｇ／ｍｌ）而增高,说明Ｌｉｐｏｆｅｃｔｉｎ可安     

稳定表达hHCN2基因 HEK293细胞系的建立

目的：培育稳定表达hHCN2基因的细胞系,建立一种表达研究心肌离子通道的有效模型。方法：通过脂质体转染的方法,将重组pcDNA3-hHCN2真核表达载体导入人胚肾细胞（HEK293细胞）,以G418压力筛选转染细胞,并对其进行全细胞膜片钳记录。结果：经600μg／ml压力筛选后,获得抗性细胞克隆,并用全细胞膜片钳技术记录到克隆hHCN2通道编码电流。结论：本实验采用脂质体转染法成功地培育出G418抗性HEK293细胞。为进一步研究克隆离子通道结构和功能的关系奠定基础。     

Targeted disruption of Nemo‐like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma

The Wnt/β‐catenin signaling pathway regulates various aspects of development and plays important role in human carcinogenesis. Nemo‐like kinase (NLK), which is mediator of Wnt/β‐catenin signaling pathway, phosphorylates T‐cell factor/lymphoid enhancer factor (TCF/LEF) factor and inhibits interaction of β‐catenin/TCF complex. Although, NLK is known to be a tumor suppressor in Wnt/β‐catenin signaling pathway of colon cancer, the other events occurring downstream of NLK pathways in other types of cancer remain unclear. In the present study, we identified that expression of NLK was significantly up‐regulated in the HCCs compared to corresponding normal tissues in five selected tissue samples. Immunohistochemical analysis showed significant over‐expression of NLK in the HCCs. Targeted‐disruption of NLK suppressed cell growth and arrested cell cycle transition. Suppression of NLK elicited anti‐mitogenic properties of the Hep3B cells by simultaneous inhibition of cyclinD1 and CDK2. The results of this study suggest that NLK is aberrantly regulated in HCC, which might contribute to the mitogenic potential of tumor cells during the initiation and progression of hepatocellular carcinoma; this process appears to involve the induction of CDK2 and cyclin D1 and might provide a novel target for therapeutic intervention in patients with liver cancer. J. Cell. Biochem. 110: 687–696, 2010. © 2010 Wiley‐Liss, Inc.     

Molecular cloning, gene localization, and structure of human cyclin B3

Here we describe the molecular cloning of human cyclin B3, its localization, and its structure. It is localized in the subcentromeric region of the X chromosome, still not completely sequenced by the Human Genome Project. This cyclin B3 is unusually large for a mitotic cyclin. Its mRNAs were found in all tissues and were particularly abundant in testis. At least three splice variants were found in the ORF and three variants in the 5'UTR.     

Canstatin基因转染对人肝癌HepG-2细胞体外血管生成拟态的影响

目的:探讨转染Canstatin基因对人肝癌HepG-2细胞体外形成血管生成拟态的影响。方法:将Canstatin基因通过脂质体法转染人肝癌HepG-2细胞,行G418筛选获得转基因细胞克隆。用SDS-PAGE电泳检测Canstatin蛋白在转基因细胞培养上清液中的表达;建立HepG-2细胞人工基底膜基质凝胶体外三维细胞培养模型,观察HepG-2细胞能否形成血管生成拟态,并比较转基因和未转基因细胞的管道形成能力。结果:Canstatin在转染人HepG-2细胞中表达并分泌至上清液中,人肝癌HepG-2细胞在体外三维培养条件下能够形成血管生成拟态。Canstatin基因转染HepG-2细胞组的管状结构数量高于空载体组和HepG-2细胞组,转染细胞管道形成能力明显受抑制。结论:人肝癌HepG-2细胞株可形成血管生成拟态,Canstatin能抑制人肝癌细胞株HepG-2体外血管生成拟态形成。     

Effects of 2-methoxyestradiol on proliferation, apoptosis and gene expression of cyclin B1 and c-Myc in esophageal carcinoma EC9706 cells

2-Methoxyestradiol (2-ME) is an endogenous metabolite of 17β-estradiol. In this study, we determined the antitumour activities of 2-ME on the well-differentiated EC9706 esophageal carcinoma cells in vitro. 2-ME had a strong antiproliferative effect on EC9706 cells and caused an increase in the population of apoptotic cells, detected by flow cytometry. A significant number of cells were blocked in the G(2)/M phase of the cell cycle. 2-ME-treated cells demonstrated an increase in cyclin B1 and c-Myc protein levels, as well as an increase in the percentage of G(2)/M phase. Their up-regulation may be involved in 2-ME-induced apoptosis and G(2)/M cell cycle arrest of the EC9706 cells, and it precedes the onset of apoptosis.     

芫菁斑蝥素对喉癌细胞和胃癌细胞的抑制作用

【目的】 研究提取自眼斑芫菁Mylabris cichorii (Linnaeus)体内的斑蝥素对人喉癌HEP-2细胞和人胃癌BGC-823细胞的抑制、以及对细胞周期分布的影响。【方法】 将斑蝥素作用于经体外培养的人喉癌HEP-2细胞和人胃癌BGC-823细胞, 采用MTT法进行体外细胞抑制实验, 测定斑蝥素对这2种癌细胞生长的抑制率与剂量效应;采用流式细胞术测定斑蝥素处理的人喉癌HEP-2细胞的细胞周期;并通过光学显微镜观察其细胞形态学改变。【结果】 斑蝥素浓度为1.28 μmol/L时, 对HEP-2细胞有显著抑制作用, 且随药物浓度升高其抑制作用增强, 呈剂量效应关系, 抑制中浓度为2.88 μmol/L;斑蝥素浓度为20.4 μmol/L时, 对BGC-823细胞有显著抑制作用, 且随药物浓度升高其抑制作用增强, 呈剂量效应关系, 抑制中浓度为54.85 μmol/L。用浓度1.44和2.88 μmol/L的斑蝥素处理HEP-2细胞24 h后, G2-M期分布从8.21%增加到22.29%, S期细胞分布从14.33%增加到21.61%, 且随药物浓度升高其阻滞作用增加, 呈剂量效应关系。G0-G1期细胞分布都有所降低, 从77.45%降低到56.10%, G0-G1期峰前无显著的亚二倍体峰出现, 说明斑蝥素未能够诱导HEP-2细胞发生凋亡。光镜检查显示：HEP-2细胞可出现细胞收缩、胞膜突出、核碎裂等现象。【结论】 斑蝥素对治疗喉癌的效果可能较为理想, 而对胃癌的作用则不明显。     

Expression of the human insulin gene in the gastric G cells of transgenic mice

The goal of this study was to engineer gastrin-producing G cells of the gastric antrum to produce insulin. A pGas-Ins chimeric gene in which the gastrin promoter drives expression of the human insulin gene was constructed and was validated by transient transfection of GH4 and AGS cells. RT-PCR analysis and sequencing revealed three forms of differentially spliced insulin mRNA in GH4 cells transiently transfected by pGas-Ins. Gas-Ins transgenic mice were generated utilizing this chimeric gene. Northern blot analysis, in situ hybridization, and immunohistochemistry demonstrated expression of the human insulin gene specifically in antral G cells. Northern blot analysis demonstrated that the shortest of the insulin mRNA three forms is predominantly expressed in stomach tissue. RT-PCR analysis also showed expression of the transgene in colon, pancreas, and brain tissues that was undetectable by northern analysis. We conclude that gastrin promoter can be used for targeting expression of human insulin to antral G cells and that antral G cells can express human insulin. Further refining of the chimeric gene design is required to enhance expression.